Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,364 | 17,495 | 18,487 | 19,696 | 20,475 |
| Marketable Securities | 8 | 10 | 45 | 113 | 208 |
| Receivables | 936 | 880 | 883 | 677 | 539 |
| Inventories | 913 | 789 | 741 | 678 | 489 |
| TOTAL | $20,293 | $21,448 | $22,208 | $21,779 | $23,024 |
| Non-Current Assets | |||||
| PPE Net | 5,558 | 5,365 | 5,388 | 5,245 | 5,153 |
| Investments And Advances | 865 | 865 | 865 | 666 | 671 |
| Intangibles | 1,480 | 1,561 | 1,654 | 2,012 | 1,469 |
| Other Non-Current Assets | 0 | 0 | 28 | 809 | 908 |
| TOTAL | $7,903 | $7,792 | $7,935 | $8,731 | $8,201 |
| Total Assets | $28,196 | $29,239 | $30,143 | $30,510 | $31,225 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,247 | 1,197 | 1,163 | 1,347 | 1,300 |
| Accounts payable and accrued liabilities | 773 | 794 | 624 | 666 | 482 |
| Accrued Expenses | 558 | 595 | 669 | 394 | 396 |
| Other current liabilities | 21 | 35 | 48 | N/A | N/A |
| TOTAL | $2,749 | $2,785 | $2,683 | $2,530 | $2,295 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -198 | -239 | -91 | -451 | -566 |
| TOTAL | $855 | $907 | $1,117 | $892 | $846 |
| Total Liabilities | $3,605 | $3,693 | $3,800 | $3,422 | $3,141 |
| Shareholders' Equity | |||||
| Common Shares | 42,429 | 42,444 | 41,787 | 41,141 | 40,639 |
| Retained earnings | -33,473 | -32,406 | -30,530 | -29,205 | -27,899 |
| Other shareholders' equity | 10,813 | 10,800 | 10,978 | 10,629 | 10,811 |
| TOTAL | $24,355 | $25,269 | $26,064 | $26,487 | $27,476 |
| Total Liabilities And Equity | $27,960 | $28,962 | $29,865 | $29,909 | $30,617 |